Genmab A GMAB
NASDAQ GMAB
$39.57 +0.50 (+1.28%)
At close: Oct 21, 2026 · 4:00 PM EDT

Genmab A (GMAB) EV to CFO (2025 - 2026)

Updated

Genmab A's EV to CFO came in at 0.20 for the quarter ended Jun 30, 2026, up 52.9% from the prior quarter.

Analysis

Genmab A (GMAB) EV to CFO (2025 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Genmab A reported EV to CFO of -2.80; for the year ended Dec 31, 2025, it was 0.22, down 54.7% from the prior year.

  • EV to CFO has declined in each of the last four years.
  • Going back by year, EV to CFO was 0.49 in the year ended Dec 31, 2024 (-39.4%), 0.81 in the year ended Dec 31, 2023 (-37.0%), 1.28 in the year ended Dec 31, 2022 (-17.0%) and 1.55 in the year ended Dec 31, 2021 (+48.5%).
  • The five-year range for quarterly EV to CFO is -0.85 (the quarter ended Jun 30, 2025) to 0.62 (the quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Genmab A 2.56 Bn -2.81 Bn 1.07 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.30
Mar 31, 2026 0.18
Sep 30, 2025 1.04
API Access

Genmab A EV to CFO API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=GMAB&period=max&api_key=YOUR_API_KEY